BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 21064154)

  • 1. A CRM1-dependent nuclear export pathway is involved in the regulation of MutLα subcellular localization.
    Brieger A; Adam R; Passmann S; Plotz G; Zeuzem S; Trojan J
    Genes Chromosomes Cancer; 2011 Feb; 50(2):59-70. PubMed ID: 21064154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear import of human MLH1, PMS2, and MutLalpha: redundancy is the key.
    Leong V; Lorenowicz J; Kozij N; Guarné A
    Mol Carcinog; 2009 Aug; 48(8):742-50. PubMed ID: 19148896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha.
    Wu X; Platt JL; Cascalho M
    Mol Cell Biol; 2003 May; 23(9):3320-8. PubMed ID: 12697830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservation of functional asymmetry in the mammalian MutLα ATPase.
    Johnson JR; Erdeniz N; Nguyen M; Dudley S; Liskay RM
    DNA Repair (Amst); 2010 Nov; 9(11):1209-13. PubMed ID: 20864418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA mismatch repair proteins MLH1 and PMS2 can be imported to the nucleus by a classical nuclear import pathway.
    de Barros AC; Takeda AAS; Dreyer TR; Velazquez-Campoy A; Kobe B; Fontes MRM
    Biochimie; 2018 Mar; 146():87-96. PubMed ID: 29175432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel interaction between human DNA polymerase eta and MutLalpha.
    Kanao R; Hanaoka F; Masutani C
    Biochem Biophys Res Commun; 2009 Nov; 389(1):40-5. PubMed ID: 19703417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MutLα heterodimers modify the molecular phenotype of Friedreich ataxia.
    Ezzatizadeh V; Sandi C; Sandi M; Anjomani-Virmouni S; Al-Mahdawi S; Pook MA
    PLoS One; 2014; 9(6):e100523. PubMed ID: 24971578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of microRNA processing by mismatch repair protein MutLα.
    Mao G; Lee S; Ortega J; Gu L; Li GM
    Cell Res; 2012 Jun; 22(6):973-85. PubMed ID: 22290424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncation of the C-terminus of human MLH1 blocks intracellular stabilization of PMS2 and disrupts DNA mismatch repair.
    Mohd AB; Palama B; Nelson SE; Tomer G; Nguyen M; Huo X; Buermeyer AB
    DNA Repair (Amst); 2006 Mar; 5(3):347-61. PubMed ID: 16338176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of MLH1 missense variants identified in Lynch syndrome patients.
    Andersen SD; Liberti SE; Lützen A; Drost M; Bernstein I; Nilbert M; Dominguez M; Nyström M; Hansen TV; Christoffersen JW; Jäger AC; de Wind N; Nielsen FC; Tørring PM; Rasmussen LJ
    Hum Mutat; 2012 Dec; 33(12):1647-55. PubMed ID: 22753075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Lynch syndrome mutations in the MLH1-PMS2 interface that disturb dimerization and mismatch repair.
    Kosinski J; Hinrichsen I; Bujnicki JM; Friedhoff P; Plotz G
    Hum Mutat; 2010 Aug; 31(8):975-82. PubMed ID: 20533529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRM1-dependent nuclear export and dimerization with hMSH5 contribute to the regulation of hMSH4 subcellular localization.
    Neyton S; Lespinasse F; Lahaye F; Staccini P; Paquis-Flucklinger V; Santucci-Darmanin S
    Exp Cell Res; 2007 Oct; 313(17):3680-93. PubMed ID: 17869244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PMS2 subunit of human MutLalpha contains a metal ion binding domain of the iron-dependent repressor protein family.
    Kosinski J; Plotz G; Guarné A; Bujnicki JM; Friedhoff P
    J Mol Biol; 2008 Oct; 382(3):610-27. PubMed ID: 18619468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyosarcoma in patients with constitutional mismatch-repair-deficiency syndrome.
    Kratz CP; Holter S; Etzler J; Lauten M; Pollett A; Niemeyer CM; Gallinger S; Wimmer K
    J Med Genet; 2009 Jun; 46(6):418-20. PubMed ID: 19293170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells.
    Peng M; Litman R; Xie J; Sharma S; Brosh RM; Cantor SB
    EMBO J; 2007 Jul; 26(13):3238-49. PubMed ID: 17581638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast.
    Vogelsang M; Comino A; Zupanec N; Hudler P; Komel R
    BMC Cancer; 2009 Oct; 9():382. PubMed ID: 19863800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intact Pms2 ATPase domain is not essential for male fertility.
    Fischer JM; Dudley S; Miller AJ; Liskay RM
    DNA Repair (Amst); 2016 Mar; 39():46-51. PubMed ID: 26753533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PMS2 involvement in patients suspected of Lynch syndrome.
    Niessen RC; Kleibeuker JH; Westers H; Jager PO; Rozeveld D; Bos KK; Boersma-van Ek W; Hollema H; Sijmons RH; Hofstra RM
    Genes Chromosomes Cancer; 2009 Apr; 48(4):322-9. PubMed ID: 19132747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
    Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MLH1 variants p.Arg265Cys and p.Lys618Ala affect protein stability while p.Leu749Gln affects heterodimer formation.
    Perera S; Bapat B
    Hum Mutat; 2008 Feb; 29(2):332. PubMed ID: 18205192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.